花旗:料友邦(1299.HK)投資中郵有助開拓大眾市場
花旗發表研究報吿指,友邦保險(1299.HK)將以約120億元人民幣認購中郵保險24.99%的股權。該行表示,該交易將有助於友邦中國開拓以前未曾涉及的顧客羣和區域,中郵保險注重大眾市場和大眾富裕階層,與友邦將實現互補。
該行指,友邦保險在提升中郵保險的產品、分銷和公司治理方面有巨大潛力,這筆投資的考量還包含友邦中國和與中郵保險同系的附屬公司郵儲銀行之間的銀保合作,友邦中國將得以利用郵儲銀行6.22億的客户羣。不過,由於中外管理方式的不同,此前的中外合資壽險公司並沒有多少成功的案例,友邦這筆投資能否結出果實很大程度上取決於未來的溝通和執行效果。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.